Have a question? Give us a call! 800-979-2869
Check out our latest deals!
Equine Rhinopneumonitis Vaccine (killed virus)
the vaccination of healthy, susceptible horses 6 months of age or
older, including pregnant mares, as an aid in the reduction of
respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4
Administration and Dosage:Shake
well before use. Using aseptic technique, inoculate horses
intramuscularly with a 2 ml dose. Administer a second 2 ml dose
intramuscularly in 3-4 weeks using a different injection site.
Administer a third 2 ml dose in 3-4 weeks by either the intramuscular
or intranasal route. Revaccinate annually and prior to anticipated
exposure, by either the intramuscular of intranasal route.
at a temperature between 35-45° F (2-7° C). Protect from freezing. Use
entire contents when first opened. Do not vaccinate within 21 days
before slaughter. Anaphylactoid reactions may occur following use.
product has been tested under laboratory conditions and shown to meet
all Federal standards for safety and efficacy in normal, healthy,
immunocompetent animals. This level of performance may be affected by
conditions such as stress, weather, nutrition, disease, parasitism,
other treatments, individual idiosyncrasies or impaired immunological
competency. These factors should be considered by the user when
evaluating product performance or freedom from reactions.
For veterinary use only.